MedTrace Logo

A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema

NCT05439577 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2022-06-30

No results posted yet for this study

Summary

The study was designed to collect information over 1800 patients with a clinical diagnosis of subacute or chronic eczema, these patients' prescriptions contain Hirudoid®. EASI, IGA and more indicators are evaluated. Data were collected for a maximum of 12 weeks according to the clinician's consultation and follow-up (Time points were set at baseline, 1, 2, 3, 4, 8 and 12 weekends). The above data were analysed to explore the optimal treatment modality, dose and treatment period for patients with subacute or chronic eczema.

Conditions

Interventions

DRUG

Mucopolysaccharide Polysulfate Cream

Patients using Hirudoid® alone

DRUG

Mucopolysaccharide Polysulfate Cream and glucocorticoids

Patients using Hirudoid® and glucocorticoids (Combination therapy, but not always)

Sponsors & Collaborators

  • Beijing Friendship Hospital

    collaborator OTHER

  • LanZhou University

    collaborator OTHER

  • The First Hospital of Hebei Medical University

    collaborator OTHER

  • Xingtai People's Hospital

    collaborator OTHER

  • Beijing Boai Hospital

    collaborator OTHER

  • Guangxi Ruikang Hospital

    collaborator OTHER

  • The Third Affiliated Hospital of Southern Medical University

    collaborator OTHER_GOV

  • The Second Affiliated Hospital of Jiaxing University

    collaborator OTHER

  • Wuxi People's Hospital

    collaborator OTHER

  • Shenzhen Kangzhe Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Lingfeng Li · Beijing Friendship Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-23
Primary Completion
2022-09-30
Completion
2022-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05439577 on ClinicalTrials.gov